MVR-T8011

N/A

Report date: 2022/11/04 14:05:18

Base Information

Drug NameMVR-T8011
Drug Alias NameMVR-T8011
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesImmvira Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmvira Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A